Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.38 |
| ▸ | AHR | P35869 | 3/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.38 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.35 |
| ▸ | TNF | P01375 | 1/20 | 0.31 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.31 |
| ▸ | IKBKB | O14920 | 1/20 | 0.31 |
| ▸ | CHUK | O15111 | 1/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8995163 | 0.80 | AHR (0.48) | CSNK2A1AHRCYP2A6NR4A2PIM3 | |
| SCHEMBL1137858 | 0.78 | AHR (0.47) | CSNK2A1AHRCYP2A6NR4A2PIM3 | |
| SCHEMBL5372066 | 0.77 | ALOX15 (0.45) | CSNK2A1AHRCYP2A6NR4A2PIM3 | |
| SCHEMBL6787752 | 0.77 | MAPT (0.41) | CSNK2A1AHRCYP2A6NR4A2PIM3 | |
| SCHEMBL5176001 | 0.77 | XDH (0.40) | CSNK2A1AHRCYP2A6NR4A2PIM3 | |
| SCHEMBL1397681 | 0.77 | CSNK2A1 (0.46) | CSNK2A1AHRCYP2A6NR4A2PIM3 | |
| SCHEMBL794596 | 0.74 | TNF (0.44) | CSNK2A1AHRTNFRIPK1IKBKB | |
| SCHEMBL985652 | 0.74 | MEN1 (0.47) | CSNK2A1AHRCYP2A6NR4A2IKBKB | |
| SCHEMBL15709253 | 0.72 | IKBKB (0.43) | CSNK2A1AHRCYP2A6NR4A2PIM3 | |
| SCHEMBL15708980 | 0.72 | CYP2A6 (0.50) | CSNK2A1AHRCYP2A6NR4A2PIM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720037-A1 | CYP26B1 INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF | 16380026 Canada Inc. (CA) | 2026-04-08 | — | — | EP | disclosed |